{"id":"https://openalex.org/W2001209027","doi":"https://doi.org/10.1111/dom.12281","title":"Linagliptin treatment in subjects with type 2 diabetes with and without mild\u2010to\u2010moderate renal impairment","display_name":"Linagliptin treatment in subjects with type 2 diabetes with and without mild\u2010to\u2010moderate renal impairment","alternate_titles":[],"publication_year":2014,"publication_date":"2014-03-24","ids":{"openalex":"https://openalex.org/W2001209027","doi":"https://doi.org/10.1111/dom.12281","mag":"2001209027","pmid":"https://pubmed.ncbi.nlm.nih.gov/24612167","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/4288982"},"language":"en","primary_location":{"id":"doi:10.1111/dom.12281","doi":"https://doi.org/10.1111/dom.12281","is_oa":true,"landing_page_url":"https://doi.org/10.1111/dom.12281","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/dom.12281","source":{"id":"https://openalex.org/S148394532","display_name":"Diabetes Obesity and Metabolism","issn_l":"1462-8902","issn":["1462-8902","1463-1326"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Obesity and Metabolism","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2001209027"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/dom.12281","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5025610737","display_name":"Per\u2010Henrik Groop","orcid":"https://orcid.org/0000-0003-4055-6954","observed_orcids":["https://orcid.org/0000-0003-4055-6954"]},"institutions":[{"id":"https://openalex.org/I142471025","display_name":"Baker Heart and Diabetes Institute","ror":"https://ror.org/03rke0285","country_code":"AU","type":"nonprofit","lineage":["https://openalex.org/I142471025"]},{"id":"https://openalex.org/I2800394112","display_name":"Helsinki University Hospital","ror":"https://ror.org/02e8hzf44","country_code":"FI","type":"healthcare","lineage":["https://openalex.org/I2800394112","https://openalex.org/I4210166427"]},{"id":"https://openalex.org/I4210165462","display_name":"Folkh\u00e4lsans Forskningscentrum","ror":"https://ror.org/05xznzw56","country_code":"FI","type":"government","lineage":["https://openalex.org/I4210165462"]}],"countries":["AU","FI"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"P.\u2010H. Groop","raw_affiliation_strings":["Baker IDI Heart and Diabetes Institute Melbourne Victoria Australia","Division of Nephrology, Department of Medicine, Helsinki University Central Hospital, Helsinki, Finland","Folkh\u00e4lsan Institute of Genetics Folkh\u00e4lsan Research Center, Biomedicum Helsinki Helsinki Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Baker IDI Heart and Diabetes Institute Melbourne Victoria Australia","institution_ids":["https://openalex.org/I142471025"]},{"raw_affiliation_string":"Division of Nephrology, Department of Medicine, Helsinki University Central Hospital, Helsinki, Finland","institution_ids":["https://openalex.org/I2800394112"]},{"raw_affiliation_string":"Folkh\u00e4lsan Institute of Genetics Folkh\u00e4lsan Research Center, Biomedicum Helsinki Helsinki Finland","institution_ids":["https://openalex.org/I4210165462"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019711625","display_name":"Stefano Del Prato","orcid":"https://orcid.org/0000-0002-5388-0270","observed_orcids":["https://orcid.org/0000-0002-5388-0270","https://orcid.org/0000-0001-5905-0211"]},"institutions":[{"id":"https://openalex.org/I108290504","display_name":"University of Pisa","ror":"https://ror.org/03ad39j10","country_code":"IT","type":"education","lineage":["https://openalex.org/I108290504"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"S. Del Prato","raw_affiliation_strings":["Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy","institution_ids":["https://openalex.org/I108290504"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057557099","display_name":"Marja\u2010Riitta Taskinen","orcid":"https://orcid.org/0000-0002-6229-3588","observed_orcids":["https://orcid.org/0000-0002-6229-3588"]},"institutions":[{"id":"https://openalex.org/I2800394112","display_name":"Helsinki University Hospital","ror":"https://ror.org/02e8hzf44","country_code":"FI","type":"healthcare","lineage":["https://openalex.org/I2800394112","https://openalex.org/I4210166427"]}],"countries":["FI"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"M.\u2010R. Taskinen","raw_affiliation_strings":["Division of Nephrology, Department of Medicine, Helsinki University Central Hospital, Helsinki, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Nephrology, Department of Medicine, Helsinki University Central Hospital, Helsinki, Finland","institution_ids":["https://openalex.org/I2800394112"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078134786","display_name":"David R. Owens","orcid":"https://orcid.org/0000-0003-1002-1238","observed_orcids":["https://orcid.org/0000-0003-1002-1238"]},"institutions":[{"id":"https://openalex.org/I39586589","display_name":"Swansea University","ror":"https://ror.org/053fq8t95","country_code":"GB","type":"education","lineage":["https://openalex.org/I39586589"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"D. R. Owens","raw_affiliation_strings":["Diabetes Research Group, Swansea University, Swansea, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Diabetes Research Group, Swansea University, Swansea, UK","institution_ids":["https://openalex.org/I39586589"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072564819","display_name":"Yan Gong","orcid":"https://orcid.org/0000-0002-8218-1620","observed_orcids":["https://orcid.org/0000-0002-8218-1620"]},"institutions":[{"id":"https://openalex.org/I1330995197","display_name":"Boehringer Ingelheim (Germany)","ror":"https://ror.org/00q32j219","country_code":"DE","type":"company","lineage":["https://openalex.org/I1330995197"]}],"countries":["DE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Y. Gong","raw_affiliation_strings":["Boehringer Ingelheim Pharma GmbH & Co. KG Ingelheim Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boehringer Ingelheim Pharma GmbH & Co. KG Ingelheim Germany","institution_ids":["https://openalex.org/I1330995197"]}]},{"author_position":"middle","author":{"id":null,"display_name":"S. Crowe","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1330995197","display_name":"Boehringer Ingelheim (Germany)","ror":"https://ror.org/00q32j219","country_code":"DE","type":"company","lineage":["https://openalex.org/I1330995197"]}],"countries":["DE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"S. Crowe","raw_affiliation_strings":["Boehringer Ingelheim Pharma GmbH & Co. KG Ingelheim Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boehringer Ingelheim Pharma GmbH & Co. KG Ingelheim Germany","institution_ids":["https://openalex.org/I1330995197"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000118493","display_name":"Sakshi Patel","orcid":"https://orcid.org/0009-0000-2041-9325","observed_orcids":["https://orcid.org/0009-0000-2041-9325"]},"institutions":[{"id":"https://openalex.org/I4210112752","display_name":"Boehringer Ingelheim (United Kingdom)","ror":"https://ror.org/01jnnpe14","country_code":"GB","type":"company","lineage":["https://openalex.org/I1330995197","https://openalex.org/I4210112752"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"S. Patel","raw_affiliation_strings":["Boehringer Ingelheim Ltd, Bracknell, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boehringer Ingelheim Ltd, Bracknell, UK","institution_ids":["https://openalex.org/I4210112752"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067356779","display_name":"Maximilian von Eynatten","orcid":"https://orcid.org/0009-0006-8443-7323","observed_orcids":["https://orcid.org/0009-0006-8443-7323"]},"institutions":[{"id":"https://openalex.org/I1330995197","display_name":"Boehringer Ingelheim (Germany)","ror":"https://ror.org/00q32j219","country_code":"DE","type":"company","lineage":["https://openalex.org/I1330995197"]}],"countries":["DE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"M. von Eynatten","raw_affiliation_strings":["Boehringer Ingelheim Pharma GmbH & Co. KG Ingelheim Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boehringer Ingelheim Pharma GmbH & Co. KG Ingelheim Germany","institution_ids":["https://openalex.org/I1330995197"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5113826021","display_name":"H.J. Woerle","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1330995197","display_name":"Boehringer Ingelheim (Germany)","ror":"https://ror.org/00q32j219","country_code":"DE","type":"company","lineage":["https://openalex.org/I1330995197"]}],"countries":["DE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"H.\u2010J. Woerle","raw_affiliation_strings":["Boehringer Ingelheim Pharma GmbH & Co. KG Ingelheim Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boehringer Ingelheim Pharma GmbH & Co. KG Ingelheim Germany","institution_ids":["https://openalex.org/I1330995197"]}]}],"institutions":[],"countries_distinct_count":5,"institutions_distinct_count":7,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5380,"currency":"USD","value_usd":5380},"apc_paid":{"value":5380,"currency":"USD","value_usd":5380},"fwci":6.6342,"has_fulltext":true,"cited_by_count":57,"citation_normalized_percentile":{"value":0.97546028,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":99},"biblio":{"volume":"16","issue":"6","first_page":"560","last_page":"568"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10408","display_name":"Chronic Kidney Disease and Diabetes","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/linagliptin","display_name":"linagliptin","score":1.0},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9440000057220459},{"id":"https://openalex.org/keywords/renal-dysfunction","display_name":"renal dysfunction","score":0.9629999995231628},{"id":"https://openalex.org/keywords/dpp-4-inhibitors","display_name":"DPP-4 inhibitors","score":0.9300000071525574},{"id":"https://openalex.org/keywords/hba1c","display_name":"HbA1c","score":0.8880000114440918},{"id":"https://openalex.org/keywords/hypoglycemia","display_name":"hypoglycemia","score":0.9120000004768372},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.6110000014305115},{"id":"https://openalex.org/keywords/renal-function","display_name":"renal function","score":0.5389999747276306}],"concepts":[{"id":"https://openalex.org/C2780031085","wikidata":"https://www.wikidata.org/wiki/Q909745","display_name":"Linagliptin","level":4,"score":0.995050311088562},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8315961360931396},{"id":"https://openalex.org/C159641895","wikidata":"https://www.wikidata.org/wiki/Q108377937","display_name":"Renal function","level":2,"score":0.7437804341316223},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.6978233456611633},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6583597660064697},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.6535478830337524},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.6103493571281433},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.5345593690872192},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.4873822331428528},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.4578304886817932},{"id":"https://openalex.org/C2778653478","wikidata":"https://www.wikidata.org/wiki/Q1054718","display_name":"Kidney disease","level":2,"score":0.4507678151130676},{"id":"https://openalex.org/C2779159551","wikidata":"https://www.wikidata.org/wiki/Q1414874","display_name":"Comorbidity","level":2,"score":0.44633233547210693},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.3330156207084656},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.2837095260620117},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000069476","descriptor_name":"Linagliptin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003928","descriptor_name":"Diabetic Nephropathies","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007003","descriptor_name":"Hypoglycemia","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010919","descriptor_name":"Placebos","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011687","descriptor_name":"Purines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D011687","descriptor_name":"Purines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D011799","descriptor_name":"Quinazolines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D011799","descriptor_name":"Quinazolines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D012720","descriptor_name":"Severity of Illness Index","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016032","descriptor_name":"Randomized Controlled Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017326","descriptor_name":"Clinical Trials, Phase III as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":5,"locations":[{"id":"doi:10.1111/dom.12281","doi":"https://doi.org/10.1111/dom.12281","is_oa":true,"landing_page_url":"https://doi.org/10.1111/dom.12281","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/dom.12281","source":{"id":"https://openalex.org/S148394532","display_name":"Diabetes Obesity and Metabolism","issn_l":"1462-8902","issn":["1462-8902","1463-1326"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Obesity and Metabolism","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:3266218","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4288982","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:4288982","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC4288982/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Obes Metab","raw_type":"Text"},{"id":"pmid:24612167","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24612167","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, obesity & metabolism","raw_type":"Journal Article"},{"id":"pmh:oai:arpi.unipi.it:11568/469670","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/11568/469670","pdf_url":null,"source":{"id":"https://openalex.org/S4377196265","display_name":"CINECA IRIS Institutial research information system (University of Pisa)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I108290504","host_organization_name":"University of Pisa","host_organization_lineage":["https://openalex.org/I108290504"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.1111/dom.12281","doi":"https://doi.org/10.1111/dom.12281","is_oa":true,"landing_page_url":"https://doi.org/10.1111/dom.12281","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/dom.12281","source":{"id":"https://openalex.org/S148394532","display_name":"Diabetes Obesity and Metabolism","issn_l":"1462-8902","issn":["1462-8902","1463-1326"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Obesity and Metabolism","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2001209027.pdf","grobid_xml":"https://content.openalex.org/works/W2001209027.grobid-xml"},"referenced_works_count":43,"referenced_works":["https://openalex.org/W1526927233","https://openalex.org/W1550111394","https://openalex.org/W1596584892","https://openalex.org/W1911149840","https://openalex.org/W1985941010","https://openalex.org/W1987852307","https://openalex.org/W1994832750","https://openalex.org/W2007493806","https://openalex.org/W2008447751","https://openalex.org/W2016622896","https://openalex.org/W2021010531","https://openalex.org/W2042689611","https://openalex.org/W2045321591","https://openalex.org/W2055864845","https://openalex.org/W2060124483","https://openalex.org/W2074142099","https://openalex.org/W2075182875","https://openalex.org/W2079841945","https://openalex.org/W2082511677","https://openalex.org/W2095682936","https://openalex.org/W2098292453","https://openalex.org/W2099707525","https://openalex.org/W2100987099","https://openalex.org/W2108361694","https://openalex.org/W2109688740","https://openalex.org/W2111824270","https://openalex.org/W2111876001","https://openalex.org/W2113412491","https://openalex.org/W2119418361","https://openalex.org/W2126870113","https://openalex.org/W2127245225","https://openalex.org/W2128714303","https://openalex.org/W2133507189","https://openalex.org/W2139634859","https://openalex.org/W2140480989","https://openalex.org/W2150359377","https://openalex.org/W2154719797","https://openalex.org/W2160391038","https://openalex.org/W2172193326","https://openalex.org/W2190748907","https://openalex.org/W2510708214","https://openalex.org/W2904387867","https://openalex.org/W4285719527"],"related_works":["https://openalex.org/W1583675849","https://openalex.org/W2138263417","https://openalex.org/W2100987099","https://openalex.org/W1990236377","https://openalex.org/W1981024765","https://openalex.org/W2147767541","https://openalex.org/W2002219851"],"abstract_inverted_index":{"AIMS:":[0],"Renal":[1,173],"disease":[2],"is":[3,235],"a":[4],"frequent":[5],"comorbidity":[6],"of":[7,20,25,35,68,122,127,200],"type":[8],"2":[9],"diabetes":[10],"mellitus":[11],"(T2DM)":[12],"and":[13,33,56,124,159,190,204,213,222,239,246],"an":[14,236],"important":[15],"factor":[16],"complicating":[17],"the":[18,31,36,143,218],"choice":[19],"glucose-lowering":[21,50],"drugs.":[22],"The":[23,198],"aim":[24],"this":[26,65],"analysis":[27,67,230],"was":[28,206],"to":[29,196],"evaluate":[30],"efficacy":[32],"safety":[34],"dipeptidyl":[37],"peptidase":[38],"(DPP)-4":[39],"inhibitor":[40],"linagliptin":[41,133,176,203,234],"(5":[42],"mg/day)":[43],"in":[44,52,217,242],"mono,":[45],"dual":[46],"or":[47,58,90,248],"triple":[48],"oral":[49],"regimens":[51],"subjects":[53,75,102,243],"with":[54,76,101,103,115,166,175,202,244],"T2DM":[55,245],"mild":[57,77,153,220,247],"moderate":[59,91,160,223,249],"renal":[60,105,145],"impairment":[61],"(RI).":[62],"METHODS:":[63],"In":[64,182],"pooled":[66,229],"three":[69,144],"24-week,":[70],"placebo-controlled,":[71],"phase":[72],"3":[73],"trials,":[74],"(estimated":[78],"glomerular":[79],"filtration":[80],"rate":[81],"(eGFR)":[82],"60-<90":[83],"ml/min/1.73":[84,94,108],"m(2)":[85],",":[86],"n":[87,96,110],"=":[88,97,111,171],"838)":[89],"RI":[92,116,154,161,221,224],"(30-<60":[93],"m(2),":[95,109],"93)":[98],"were":[99,117,194],"compared":[100],"normal":[104,148],"function":[106,146,174],"(\u226590":[107],"1212).":[112],"RESULTS:":[113],"Subjects":[114],"older,":[118],"had":[119],"longer":[120],"duration":[121],"diabetes,":[123],"increased":[125],"prevalence":[126],"diabetes-related":[128],"comorbidities.":[129],"After":[130],"24":[131],"weeks,":[132],"achieved":[134],"consistent":[135],"placebo-corrected":[136],"mean":[137],"glycated":[138],"haemoglobin":[139],"(HbA1c)":[140],"changes":[141],"across":[142,179],"categories:":[147],"(-0.63%;":[149],"p":[150,156,163],"<":[151,157,164],"0.0001),":[152],"(-0.67%;":[155],"0.0001)":[158],"(-0.53%;":[162],"0.01),":[165],"no":[167],"inter-group":[168],"difference":[169],"(p":[170],"0.74).":[172],"remained":[177],"stable":[178],"all":[180],"categories.":[181],"linagliptin-treated":[183],"subjects,":[184],"overall":[185],"adverse":[186],"event":[187],"(AE)":[188],"rates":[189,193],"serious":[191],"AE":[192],"similar":[195],"placebo.":[197],"incidence":[199],"hypoglycaemia":[201],"placebo":[205],"11.1":[207],"versus":[208,211,215],"6.9%,":[209],"11.9":[210],"9.0%":[212],"15.9":[214],"12.0%":[216],"normal,":[219],"categories,":[225],"respectively.":[226],"CONCLUSIONS:":[227],"This":[228],"provides":[231],"evidence":[232],"that":[233],"effective,":[237],"well-tolerated":[238],"convenient":[240],"treatment":[241],"RI.":[250]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2001209027","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":9},{"year":2016,"cited_by_count":14},{"year":2015,"cited_by_count":8},{"year":2014,"cited_by_count":4}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
